The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr NA
start NA
end NA
strand NA
Geng Symbol NA
circRNA name circGFRA1
methods qRT-PCR,Microarray,Luciferase assay,RIP,Western blot,etc.
regulated Down?
Function Description Results:Microarray analysis and qRT-PCR verified a circRNA termed circGFRA1 that was upregulated in TNBC. Kaplan-Meier survival analysis showed that upregulated circGFRA1 was correlated with poorer survival. Knockdown ofcircGFRA1 inhibited proliferation and promoted apoptosis in TNBC. Via luciferase reporter assays, circGFRA1 and GFRA1was observed to directly bind to miR-34a. Subsequent experiments showed that circGFRA1 and GFRA1 regulated theexpression of each other by sponging miR-34a.Conclusions:Taken together, we conclude that circGFRA1 may function as a competing endogenous RNA (ceRNA) toregulate GFRA1 expression through sponging miR-34a to exert regulatory functions in TNBC. circGFRA1 may be adiagnostic biomarker and potential target for TNBC therapy.
PMID 29037220
year 2017
Title circGFRA1 and GFRA1 act as ceRNAs in tri-ple negative breast cancer by regulating miR-34a.
drug X
circulating X
survival V

CopyRight © University of Miami, USA; Harbin Medical University, China